The 18 references without contexts in paper A. Smirnov V., V. Dobronravov A., V. Sipovskii G., I. Trofimenko I., I. Pirozhkov A., I. Kayukov G., K. Lebedev I., А. Смирнов В., В. Добронравов А., В. Сиповский Г., И. Трофименко И., И. Пирожков А., И. Каюков Г., К. Лебедев И. (2014) “КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ ПО ДИАГНОСТИКЕ, ЛЕЧЕНИЮ И ПРОГНОЗУ МЕМБРАНОПРОЛИФЕРАТИВНОГО ГЛОМЕРУЛОНЕФРИТА // CLINICAL PRACTICE GUIDELINE FOR DIAGNOSTICS., TREATMENT AND PROGNOSIS OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS” / spz:neicon:nefr:y:2014:i:6:p:82-93

1
Добронравов В.А., Дунаева Н.В. Поражение почек и хронический вирусный гепатит С. Нефрология 2008; 12 (4): 9-19 [Dobronravov V.A., Dunaeva N.V. Porazhenie pochek i khronicheskii` virusny`i` gepatit S. Nefrologiia 2008; 12 (4): 9-19]
(check this in PDF content)
2
Лора Ш., Фремю-Бачи В. Атипичный гемолитико- уремический синдром. Нефрология 2012; 16 (2): 16-48 [Lora Sh., Fremiu-Bachi V. Atipichny`i` gemolitiko- uremicheskii` sindrom. Nefrologiia 2012; 16 (2): 16-48]
(check this in PDF content)
3
Ферри С. Смешанная криоглобулинемия. Нефрология 2010; 14 (1): 11-28 [Ferri S. Smeshannaia krioglobulinemiia. Nefrologiia 2010; 14 (1): 11-28]
(check this in PDF content)
4
Appel G.B. Membranoproliferative glomerulonephritis - mechanisms and treatment// Contrib Nephrol. 2013; 181: 163-174
(check this in PDF content)
5
D’Agati V.D., Bomback A.S. C3 glomerulopathy: what’s in a name?// Kidney Int. 2012; 82: 379-381
(check this in PDF content)
6
Bomback A.S., Appel G.B. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN// Nat. Rev. Nephrol. 2012; 8: 634-642
(check this in PDF content)
7
Bomback A.S., Smith R.J., Barile G.R. et al. Eculisumab for dense deposit disease and C3 glomerulonephritis// Clin. J. Am. Soc. Nephrol. 2012; 7: 748- 756
(check this in PDF content)
8
KDIGO Clinical practice guideline for glomerulonephritis// Kidney Int. Suppl. 2012; 2(2): 198- 200
(check this in PDF content)
9
Fervensa F.C., Sethi S., Glassock R.J. Idiopathic membraneproliferative glomerulonephritis: does it exist?// Nephrol Dial Transpant. 2012; 27(12): 4288-42-94
(check this in PDF content)
10
Fregonese L., Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical conseguence// Orphanet J. Rare Diseases. 2008; 3: 16
(check this in PDF content)
11
Hou J., Markowitz G.S., Bomback A.S. et al. Toward a working definition of C3 glomerulopathy by immunofluorescence // Kidney Int 2013; Sept 25 [Epub ahead of print]
(check this in PDF content)
12
Morales J.M., Kamar N., Rostaing L. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy// Contrib Nephrol. Bazel Karger 2012; 176: 10-23
(check this in PDF content)
13
Pickering M.C., Cook H.H. Complement and glomerular disease: new insights// Curr Opin. Nephrol Hypertens. 2011; 20: 271-277
(check this in PDF content)
14
Pickering M.C., D’Agati V.D., Nester C.M. et al. C3 glomerulopathy: consensus report// Kidney Int 2013, Oct 30 [Epub ahead of print]
(check this in PDF content)
15
Sethi S., Fervenza F.C. Memranoproliferative glomerulonephritis – a new look at an old entity// N. Engl. J. Med. 2012; 366: 1119- 1131
(check this in PDF content)
16
Servias A., Noёl L-H., Roumenina L.T. et al. Acguired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies// Kidney Int 2012; 82: 454-464
(check this in PDF content)
17
Smith R.J.H., Harris C.Z., Pickering M.C. Dense Deposit Disease// Mol. Immunol. 2011; 48: 1604- 1610
(check this in PDF content)
18
Sun Q., Huang X., Jiang S. et al. Picking transplant glomerulopathy out of the CAN: evidence from a clinico- pathological evaluation// BMC Nephrology 2012; 13: 128 Авторы заявляют об отсутствии конфликта интересов.
(check this in PDF content)